•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A06393 Summary:

BILL NOA06393
 
SAME ASSAME AS S05209
 
SPONSORPaulin
 
COSPNSR
 
MLTSPNSR
 
Amd §290, Pub Health L
 
Expands the drug take back act to include single-use and reusable electronic cigarettes.
Go to top    

A06393 Actions:

BILL NOA06393
 
04/06/2023referred to health
01/03/2024referred to health
Go to top

A06393 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A6393
 
SPONSOR: Paulin
  TITLE OF BILL: An act to amend the public health law, in relation to expanding the drug take back act to include single-use and reusable electronic cigarettes   PURPOSE OR GENERAL IDEA OF BILL: The purpose of this legislation is to expand the drug take back act by designating single-use and reusable electronic cigarettes as covered drugs.   SUMMARY OF SPECIFIC PROVISIONS: Section one amends subdivision 2 of section 290 of the public health law to provide that single-use and reusable electronic cigarettes are defined as covered drugs that can be returned to a drug take back site. Section two states the effective date.   JUSTIFICATION: Five disposable vapes are thrown away every second by young people in the United States, despite their utilization of lithium-ion batteries. A survey of almost 3,000 young people by Truth Initiative, a public health organization working to end smoking and vaping, revealed that more than half of l5-to-24 year olds who vape use disposable devices. Of those, two thirds discard devices straight into their household trash. Vapes (or e-cigarettes) use lithium-ion batteries to heat a liquid that is inhaled. Even though most disposable vapes contain, a rechargeable battery, they are designed and marketed to be discarded once the liquid runs out'. The toxic nature of lithium-ion batteries drastically increases their propensity to catch fire, and designates them as hazardous waste. The Environmental Protection Agency (EPA) reported 245 fires that were caused by lithium-ion batteries between 2013 and 2020 in waste facili- ties including garbage trucks and warehouses. Furthermore, e-cigarettes can introduce plastic, nicotine salts, heavy metals, lead, and mercury into the environment. These devices become pollution and break down into toxic microplastics and chemicals that make their way into storm drains and contaminate water sources. The Drug Take Back Act created a program that mandates manufacturers to establish, fund, and manage a New York State approved drug take back program(s) for the safe collection and disposal of covered drugs. This program ensures controlled substances are returned to secure sites, such as pharmacies, which prevents them from being accessed by other individ- uals, and stops them from polluting waterways and soil. By designating single-use and reusable electronic cigarettes as a substance that can be returned to drug take back sites, this legislation can fill the gap in our current system for both combatting the use of harmful e-cigarettes, as well as protecting our waterways and wildlife.   PRIOR LEGISLATIVE HISTORY: This is a new bill.   FISCAL IMPLICATIONS: To be determined   EFFECTIVE DATE: This act shall take effect on the one hundred eightieth day after it shall have become a law (1)https://www.thebureauinvestigates.com/stories/2022-12-15/ lithium-be- ing-trashed-by-the-tonne-as-disposable- vapes-flood-us-market
Go to top

A06393 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          6393
 
                               2023-2024 Regular Sessions
 
                   IN ASSEMBLY
 
                                      April 6, 2023
                                       ___________
 
        Introduced by M. of A. PAULIN -- read once and referred to the Committee
          on Health
 
        AN ACT to amend the public health law, in relation to expanding the drug
          take back act to include single-use and reusable electronic cigarettes
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Subdivision 2 of section 290 of the public health  law,  as
     2  added by chapter 120 of the laws of 2018, is amended to read as follows:
     3    2.  "Covered  drug"  means any substance recognized as a drug under 21
     4  USC § 321(g)(1), as amended, and any regulations promulgated  thereunder
     5  that  is  sold,  offered  for  sale  or  dispensed in the state, whether
     6  directly or through a wholesaler, in any form including prescription and
     7  nonprescription  drugs,  drugs  in  medical  devices   and   combination
     8  products, brand and generic drugs and drugs for veterinary use; provided
     9  however, covered drug shall additionally include single-use and reusable
    10  electronic  cigarettes  as  defined  in section thirteen hundred ninety-
    11  nine-aa of  this  chapter;  provided  however  covered  drug  shall  not
    12  include:  (a)  vitamins  or  supplements;  (b) herbal-based remedies and
    13  homeopathic drugs, products or remedies; (c) cosmetics,  soap  (with  or
    14  without  germicidal agents), laundry detergent, bleach, household clean-
    15  ing products, shampoos, sunscreens, toothpaste,  lip  balm,  antiperspi-
    16  rants or other personal care products that are regulated as both cosmet-
    17  ics and nonprescription drugs under the Federal Food, Drug, and Cosmetic
    18  Act; (d) pet pesticide products contained in pet collars, powders, sham-
    19  poos,  topical  applications, or other forms; (e) drugs that are biolog-
    20  ical products as defined in subdivision twenty-seven of  section  sixty-
    21  eight  hundred  two  of  the  education  law if the manufacturer already
    22  provides a take  back  program;  (f)  drugs  for  which  a  manufacturer
    23  provides a take back program as part of a Federal Food and Drug Adminis-
    24  tration  managed  risk  evaluation  and mitigation strategy; (g) emptied
    25  injector products or emptied medical devices and their  component  parts
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD09080-01-3

        A. 6393                             2
 
     1  or  accessories;  and  (h)  drugs  that  are  used  solely in a clinical
     2  setting.
     3    § 2. This act shall take effect on the one hundred eightieth day after
     4  it  shall have become a law. Effective immediately, the addition, amend-
     5  ment and/or repeal of any rule or regulation necessary for the implemen-
     6  tation of this act on its effective date are authorized to be  made  and
     7  completed on or before such effective date.
Go to top